Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
15 studies found for:    "Pemphigus vulgaris"
Show Display Options
RSS Create an RSS feed from your search for:
"Pemphigus vulgaris"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: Enbrel (Etanercept)
2 Completed Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone
Condition: Pemphigus Vulgaris
Interventions: Drug: Azathioprine;   Drug: Prednisone;   Drug: Placebo
3 Recruiting Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Interventions: Drug: VAY736;   Drug: Placebo to VAY736
4 Completed Use of KC706 for the Treatment of Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: KC706
5 Completed Safety Study of PI-0824 to Treat Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: PI-0824
6 Terminated Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: Dapsone
7 Recruiting A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris
Condition: Pemphigus Vulgaris
Intervention: Drug: PRN1008
8 Recruiting A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Rituximab Versus MMF in Patients With Pemphigus Vulgaris
Condition: Pemphigus Vulgaris (PV)
Interventions: Other: MMF placebo;   Drug: mycophenolate mofetil;   Drug: rituximab [MabThera/Rituxan];   Other: rituximab placebo
9 Completed
Has Results
A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)
Condition: Pemphigus Vulgaris (PV)
Interventions: Drug: Mycophenolate Mofetil 2 g/Day;   Drug: Mycophenolate Mofetil (MMF) 3 g/Day;   Drug: Placebo
10 Recruiting Comparison Between Injections of Steroids and Autologous Platelet Rich Plasma in the Oral Erosions of Pemphigus Vulgaris
Condition: Oral Pemphigus Vulgaris
Interventions: Other: Autologous Platelet rich plasma;   Drug: Triamcinolone Acetonide
11 Terminated
Has Results
Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus
Condition: Pemphigus Vulgaris
Interventions: Drug: intravenous immunoglobulin;   Drug: cyclophosphamide
12 Terminated Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris
Condition: Pemphigus
Interventions: Drug: Ofatumumab;   Drug: Acetaminophen/paracetamol;   Drug: Antihistamine (cetirizine or equivalent);   Drug: Prednisone/Prednisolone
13 Terminated Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris
Condition: Pemphigus
Interventions: Biological: Ofatumumab;   Biological: Placebo
14 Recruiting Autoimmune Blistering Diseases Study
Conditions: Pemphigus Vulgaris;   Pemphigus Foliaceus;   Bullous Pemphigoid
Intervention: Other: Questionnaires
15 Completed
Has Results
Use of Infliximab for the Treatment of Pemphigus Vulgaris
Condition: Pemphigus
Interventions: Drug: Infliximab;   Drug: Prednisone;   Other: Placebo

Indicates status has not been verified in more than two years